blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2167136

EP2167136 - MOLECULES FOR TARGETING COMPOUNDS TO VARIOUS SELECTED ORGANS OR TISSUES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.02.2017
Database last updated on 20.09.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG
published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
BioMarin Technologies B.V.
J.H. Oortweg 21
2333 CH Leiden / NL
For all designated states
Academisch Ziekenhuis Leiden
Albinusdreef 2
2333 ZA Leiden / NL
[2016/13]
Former [2015/50]For all designated states
BioMarin Technologies B.V.
J.H. Oortweg 21
2333 CH Leiden / NL
Former [2014/52]For all designated states
Prosensa Technologies B.V.
J.H. Oortweg 21
2333 CH Leiden / NL
Former [2010/13]For all designated states
Prosensa Technologies B.V.
Wassenaarseweg 72
2333 AL Leiden / NL
Inventor(s)01 / HEEMSKERK, Johannes, Antonius
Lopsenstraat 14
NL-2312 ZZ Leiden / NL
02 / VAN DEUTEKOM, Judith, Christina, Theodora
Abeelstraat 13
NL-3329 AA Dordrecht / NL
03 / VAN KUIK-ROMEIJN, Petra
Verlengde Hoogravenseweg 82
NL-3525 BJ Utrecht / NL
04 / PLATENBURG, Gerardus, Johannes
Wijngaardenlaan 56
NL-2252 XR Voorschoten / NL
 [2010/22]
Former [2010/13]01 / HEEMSKERK, Johannes, Antonius
Lopsenstraat 14
NL-2312 ZZ Leiden / NL
02 / VAN DEUTEKOM, Judith, Christina, Theodora
Abeelstraat 13
NL-3329 AA Dordrecht / NL
03 / VAN KUIK-ROMEIJN, Petra
Verlengde Hoogravenseweg 82
NL-3525 BJ Utrecht / NL
04 / PLATENBURG, Gerard, Johannes
Wijngaardenlaan 56
NL-2252 XR Voorschoten / NL
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2013/28]
Former [2010/13]Swinkels, Bart Willem, et al
Nederlandsch Octrooibureau J. W. Frisolaan 13
2517 JS Den Haag / NL
Application number, filing date08779023.414.07.2008
[2010/13]
WO2008NL50475
Priority number, dateEP2007011232312.07.2007         Original published format: EP 07112323
[2016/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009008727
Date:15.01.2009
Language:EN
[2009/03]
Type: A2 Application without search report 
No.:EP2167136
Date:31.03.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 15.01.2009 takes the place of the publication of the European patent application.
[2010/13]
Type: B1 Patent specification 
No.:EP2167136
Date:20.04.2016
Language:EN
[2016/16]
Search report(s)International search report - published on:EP13.08.2009
ClassificationIPC:A61K47/48, A61K49/00, A61P21/00, A61P5/00
[2015/47]
CPC:
A61K49/0056 (EP,US); A61K47/62 (EP,US); A61K49/0032 (EP,US);
A61K49/0047 (EP,US); A61P19/00 (EP); A61P21/00 (EP);
A61P21/02 (EP); A61P21/04 (EP); A61P3/00 (EP);
A61P3/04 (EP); A61P3/10 (EP); A61P5/00 (EP);
A61P9/00 (EP) (-)
Former IPC [2010/13]A61K47/48, A61P19/00, A61P21/00, A61P5/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/16]
Former [2010/13]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
BANot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:MOLEKÜLE FÜR TARGETING VON VERBINDUNGEN AUF VERSCHIEDENE AUSGEWÄHLTE ORGANE ODER GEWEBE[2010/13]
English:MOLECULES FOR TARGETING COMPOUNDS TO VARIOUS SELECTED ORGANS OR TISSUES[2010/13]
French:MOLÉCULES POUR CIBLER LES COMPOSANTS VERS PLUSIEURS ORGANES SÉLECTIONNÉS OU TISSUS[2010/13]
Entry into regional phase18.01.2010National basic fee paid 
18.01.2010Designation fee(s) paid 
18.01.2010Examination fee paid 
Examination procedure18.01.2010Amendment by applicant (claims and/or description)
18.01.2010Examination requested  [2010/13]
11.08.2010Despatch of a communication from the examining division (Time limit: M04)
17.11.2010Reply to a communication from the examining division
18.09.2015Despatch of a communication from the examining division (Time limit: M02)
13.10.2015Reply to a communication from the examining division
28.10.2015Communication of intention to grant the patent
26.02.2016Fee for grant paid
26.02.2016Fee for publishing/printing paid
26.02.2016Receipt of the translation of the claim(s)
Divisional application(s)EP12174179.7  / EP2505211
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.08.2010
Opposition(s)23.01.2017No opposition filed within time limit [2017/13]
Fees paidRenewal fee
25.06.2010Renewal fee patent year 03
23.06.2011Renewal fee patent year 04
26.06.2012Renewal fee patent year 05
28.06.2013Renewal fee patent year 06
30.06.2014Renewal fee patent year 07
27.07.2015Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.07.2008
BG20.04.2016
CZ20.04.2016
EE20.04.2016
HR20.04.2016
IS20.04.2016
LT20.04.2016
LV20.04.2016
PL20.04.2016
RO20.04.2016
SI20.04.2016
SK20.04.2016
NO20.07.2016
MT31.07.2016
[2018/38]
Former [2018/33]HU14.07.2008
CZ20.04.2016
EE20.04.2016
HR20.04.2016
IS20.04.2016
LT20.04.2016
LV20.04.2016
PL20.04.2016
RO20.04.2016
SI20.04.2016
SK20.04.2016
NO20.07.2016
MT31.07.2016
Former [2018/28]HU14.07.2008
CZ20.04.2016
EE20.04.2016
HR20.04.2016
LT20.04.2016
LV20.04.2016
PL20.04.2016
RO20.04.2016
SI20.04.2016
SK20.04.2016
NO20.07.2016
Former [2017/37]CZ20.04.2016
EE20.04.2016
HR20.04.2016
LT20.04.2016
LV20.04.2016
PL20.04.2016
RO20.04.2016
SI20.04.2016
SK20.04.2016
NO20.07.2016
Former [2017/10]CZ20.04.2016
EE20.04.2016
HR20.04.2016
LT20.04.2016
LV20.04.2016
PL20.04.2016
RO20.04.2016
SK20.04.2016
NO20.07.2016
Former [2017/09]CZ20.04.2016
EE20.04.2016
HR20.04.2016
LT20.04.2016
LV20.04.2016
PL20.04.2016
RO20.04.2016
NO20.07.2016
Former [2016/51]HR20.04.2016
LT20.04.2016
LV20.04.2016
PL20.04.2016
NO20.07.2016
Former [2016/49]LT20.04.2016
PL20.04.2016
NO20.07.2016
Former [2016/46]LT20.04.2016
NO20.07.2016
Cited inInternational search[Y]US6329501  (SMITH BRUCE F [US], et al) [Y] 1-14 * the whole document *;
 [Y]US6399575  (SMITH BRUCE F [US], et al) [Y] 1-14 *Peptide LPLTPLP corresponds to SEQ ID NO: 93 of the present application*;; figure -; example -; claim 2 *;
 [Y]WO03037172  (GPC BIOTECH INC [US], et al) [Y] 1-14 * Peptide QLFTSAS (RN 518998-15-7) is identical to SEQ ID NO: 3 of the present application; Peptide GNTPSRA is identical to SEQ ID NO: 17 of the present application*;; figure -; example - *;
 [Y]  - SMITH B F ET AL, "Muscle-specific peptide #5", GENESEQ,, (19000101), XP002442550 [Y] 1-14 *abstract*
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.